Summary & Overview
CPT 0820T: Continuous In‑Person Monitoring During Psychedelic Therapy
CPT code 0820T designates continuous, in‑person monitoring and intervention by the first physician or other qualified healthcare professional during a patient’s psychedelic medication therapy, billed hourly. The code captures services aimed at managing intense emotional and physiological responses that can occur during psychedelic-assisted therapeutic sessions, making it relevant as psychedelic treatments expand in clinical practice and payer coverage considerations. Nationally, this code matters because it defines a time-based, clinician-delivered component critical to patient safety and clinical oversight during these specialized treatment sessions.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical intent and billing mechanics, typical sites of service, and the common modifiers associated with reporting this service. The publication summarizes benchmarking context where available, outlines potential policy and reimbursement considerations relevant to adoption of psychedelic-assisted therapies, and provides clinical context about why continuous in-person monitoring is documented separately from medication administration.
Intended readers will learn how the code is defined, which payers are relevant in national conversations about coverage, and what topics to expect in deeper sections such as billing rules, documentation expectations, and payer-specific policies. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 0820T describes a service in which a physician or other qualified healthcare professional (QHP) provides continuous, in‑person monitoring and intervention during a patient’s psychedelic medication therapy. This service is reported per hour and is specific to the first physician or other QHP present.
Service type: Continuous in-person monitoring and therapeutic intervention during psychedelic medication therapy
Typical site of service: Behavioral health or specialty clinic setting where psychedelic-assisted therapy is administered, with the provider physically present for the duration of the monitored session.
Clinical & Coding Specifications
Clinical Context
A 42-year-old patient with treatment‑resistant major depressive disorder presents for a scheduled in‑person psychedelic medication therapy session. The facility is a monitored treatment suite within an outpatient psychiatric clinic or licensed behavioral health center. A credentialed physician or other qualified healthcare professional (QHP) documents informed consent, completes pre‑session medical and psychiatric assessment, and remains continuously on‑site, providing direct, continuous observation and intervention during the medication administration and acute effect period. The standard workflow includes pre‑session vital signs and medication reconciliation, one‑to‑one continuous monitoring during the active psychedelic experience (typically several hours, billed per hour using 0820T for the first physician/QHP), management of adverse physiological responses (e.g., hypertension, tachycardia), provision of emotional support or grounding interventions, and post‑session reassessment with discharge instructions and documentation of time units. Typical site of service is an outpatient behavioral health clinic, ambulatory surgery center adapted for monitored psychedelic therapy, or designated inpatient psychiatric unit when medically indicated.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased Procedural Services | Use when the monitoring session requires substantially greater physician work than typical (document rationale and time-linked elements). |